T1	Participants 153 236	individuals with serious mental illness (SMI) receiving antipsychotic drug therapy.
T2	Participants 479 513	individuals with SMI over 8 weeks.
T3	Participants 521 556	30 individuals (BMI â‰¥ 28 kg/m(2))
T4	Participants 674 698	for individuals with SMI
T5	Participants 1330 1375	in patients taking antipsychotic medications;
